This is a working overview of clinical evidence, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-11-25. Anything still debated is marked as such rather than presented as settled.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
| Property | Value | Notes |
|---|---|---|
| Typical subjects | Rats and mice | Animal models |
| Common routes | Injection and oral | Route varies by study |
| Reported dose range | Microgram to milligram per kg | Not standardized across work |
| Frequent endpoints | Tissue repair, angiogenesis | Marker-dependent |
| Human evidence | Limited | Mostly small or preliminary studies |
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
==== During chronic infection and sepsis ==== T cell exhaustion can be triggered by several factors like persistent antigen exposure and lack of CD4 T cell help. Antigen exposure also has effect on the course of exhaustion because longer exposure time and higher viral load increases the severity of T cell exhaustion. At least 2–4 weeks exposure is needed to establish exhaustion. Another factor able to induce exhaustion are inhibitory receptors including programmed cell death protein 1 (PD1), CTLA-4, T cell membrane protein-3 (TIM3), and lymphocyte activation gene 3 protein (LAG3). Soluble molecules such as cytokines IL-10 or TGF-β are also able to trigger exhaustion. Last known factors that can play a role in T cell exhaustion are regulatory cells. Treg cells can be a source of IL-10 and TGF-β and therefore they can play a role in T cell exhaustion. Furthermore, T cell exhaustion is reverted after depletion of Treg cells and blockade of PD1. T cell exhaustion can also occur during sepsis as a result of cytokine storm. Later after the initial septic encounter anti-inflammatory cytokines and pro-apoptotic proteins take over to protect the body from damage. Sepsis also carries high antigen load and inflammation. In this stage of sepsis T cell exhaustion increases. Currently there are studies aiming to utilize inhibitory receptor blockades in treatment of sepsis.
The Knights Templar Cartel (Spanish: Caballeros Templarios) was created in Michoacán in 2011 after the presumed death of the leader of La Familia Michoacana, Nazario Moreno González. The cartel was headed by Enrique Plancarte Solís and Servando Gómez Martínez ("La Tuta"), who formed the Knights Templar due to differences with José de Jesús Méndez Vargas, who had assumed leadership of La Familia Michoacana. The cartel was reported to promote a religious doctrine as part of its identity. Sizable battles flared up in 2011 between the Knights Templar and La Familia. The organization grew from a splinter group to a dominant force in Michoacán, and following the arrest of Méndez Vargas, the cartel appeared to have taken over the bulk of La Familia's operations. In 2011 the Knights Templar appeared to have aligned with the Sinaloa Federation in an effort to root out the remnants of La Familia and to prevent Los Zetas from gaining foothold in the Michoacán region. In 2014 Plancarte Solís was killed by the Mexican Navy, and Gómez Martínez was arrested in 2015. The cartel is believed to have disbanded in 2017.
== Uses == Ninhydrin can be used in Kaiser test to monitor deprotection in solid phase peptide synthesis. The chain is linked via its C-terminus to the solid support, with the N-terminus extending off it. When that nitrogen is deprotected, a ninhydrin test yields blue. Amino-acid residues are attached with their N-terminus protected, so if the next residue has been successfully coupled onto the chain, the test gives a colorless or yellow result. Ninhydrin is also used in qualitative analysis of proteins. Most of the amino acids, except proline, are hydrolyzed and react with ninhydrin. Also, certain amino acid chains are degraded. Therefore, separate analysis is required for identifying such amino acids that either react differently or do not react with ninhydrin at all. The rest of the amino acids are then quantified colorimetrically after separation by chromatography. Oftentimes specialized amino acid analyzers using HPLC technology and post-column derivatization with ninhydrin are applied for the detection of free and protein-bound amino acids, as required throughout the EU in the feed industry. A solution suspected of containing the ammonium ion can be tested by ninhydrin by dotting it onto a solid support (such as silica gel); treatment with ninhydrin should result in a dramatic purple color if the solution contains this species. In the analysis of a chemical reaction by thin layer chromatography (TLC), the reagent can also be used (usually 0.2% solution in either n-butanol or in ethanol).
Sources: en.wikipedia.org
== Medical uses == Remifentanil is used as an opioid analgesic that has a rapid onset and rapid recovery time. It has been used effectively during craniotomies, spinal surgery, cardiac surgery, and gastric bypass surgery. While opioids function similarly, with respect to analgesia, the pharmacokinetics of remifentanil allows for quicker post-operative recovery. Remifentanil can be administered as part of an anesthesia technique called TIVA (total intravenous anesthesia) using computer controlled infusion pumps in a process called TCI (target controlled infusion). A target plasma concentration is entered as ng/mL into the pump, which calculates its infusion rate according to patient factors like age and weight. Induction levels of 40 ng/mL are commonly used, but it generally varies between 3–8 ng/mL. For certain surgical procedures that produce particularly strong stimuli a level of up to 15 ng/mL might be needed. The relatively short context-sensitive half-life of remifentanil allows the desired blood plasma level to be achieved quickly, and also for the same reason, recovery occurs quickly. This allows remifentanil to be used in unique circumstances such as cesarean section. Remifentanil's short context-sensitive half-life makes it ideal for intense pain of short duration. As such, it has been used for analgesia in labor successfully; however, it is not as effective as epidural analgesia. In combination with propofol, remifentanil is used for anesthesia of patients undergoing electroconvulsive therapy.
== Uses == Gamma-Butyrolactone is used as a chemical solvent and a cleaning agent, for example in paint stripping or for cleaning graffiti. Butyrolactone is a precursor to other chemicals. Reaction with methylamine gives NMP, and with ammonia gives pyrrolidone. It is also used as a solvent in lotions and some polymers.
Shortly after the start of the crisis, the Danish Realm began rapidly expanding its military capabilities in the Arctic. On 27 January 2025, its governments agreed to the First Agreement on the Arctic and North Atlantic, which invested a total of kr. 14.6 billion (US$2.05 billion) into warning systems in the Faroe Islands and Greenland, new naval vessels, drone warfare training, a new radiation monitoring station in East Greenland, upgrades to the Joint Arctic Command in Nuuk and intelligence, satellite surveillance, two new coastal radars, and Arctic basic military training in Kangerlussuaq. This was followed by the Second Agreement on 10 October 2025, providing upgrades worth kr. 27.4 billion (US$4.26 billion) for improvements of what was presented in the First Agreement, alongside upgrades to Kangerlussuaq Airport, a new specialised Arctic unit under the Jaeger Corps of the Special Operations Command that could operate anywhere in Greenland, establishment of radar capability in East Greenland, establishment of a Greenlandic reconnaissance Unit, and the construction of a new undersea cable connecting Greenland to mainland Denmark. In summer 2025, the Greenlandic government and the Danish Defence both announced that Greenland would have increased military presence by September, as part of Operation Arctic Light. On 18 August 2025, the Ministry of Justice allocated a package worth more than kr. 850 million to their operations in Greenland and the Faroe Islands.
=== Role in limb regeneration === Scientists have elucidated that as well as eating up material debris, macrophages are involved in the typical limb regeneration in the salamander. They found that removing the macrophages from a salamander resulted in failure of limb regeneration and a scarring response.
Sources: en.wikipedia.org
the Scottish Parliament, with 129 members elected under the additional member system every five years, and each called Member of the Scottish Parliament (MSP; Scottish Gaelic: Ball Pàrlamaid na h-Alba, BPA; Scots: Memmer o the Scots Pairliament, MSP) the Northern Ireland Assembly, with 90 members each known as Member of the Legislative Assembly (MLA; Irish: Comhalta den Tionól Reachtach, CTR; Ulster-Scots: Laa-Makkan Forgaitherar, LMF). (Between 1921 and 1973, Northern Ireland was governed by the bicameral Parliament of Northern Ireland. Members of its lower house, the House of Commons of Northern Ireland, were known as Member of Parliament.) the Senedd (Welsh Parliament), with 60 elected members called Member of the Senedd (English - MS); Welsh: Aelod o'r Senedd, AS) the London Assembly, with 25 members elected under the additional member system every four years, called Members of the London Assembly (AM) MPs are elected in general elections and by-elections to represent constituencies, and may remain MPs until Parliament is dissolved. "If it has not been dissolved earlier, a Parliament dissolves at the beginning of the day that is the fifth anniversary of the day on which it first met." (Dissolution and Calling of Parliament Act 2022). A candidate to become an MP must be a British or Irish or Commonwealth citizen, be at least 18 years of age (reduced from 21 in 2006), and not be a public official or officeholder, as set out in the schedule to the Electoral Administration Act 2006.
Lymph enters the convex side of a lymph node through multiple afferent lymphatic vessels, which form a network of lymphatic vessels (Latin: plexus) and flows into a space (Latin: sinus) underneath the capsule called the subcapsular sinus. From here, lymph flows into sinuses within the cortex. After passing through the cortex, lymph then collects in medullary sinuses. All of these sinuses drain into the efferent lymphatic vessels to exit the node at the hilum on the concave side. These are channels within the node lined by endothelial cells along with fibroblastic reticular cells, allowing for the smooth flow of lymph. The endothelium of the subcapsular sinus is continuous with that of the afferent lymph vessel and also with that of the similar sinuses flanking the trabeculae and within the cortex. These vessels are smaller and do not allow the passage of macrophages so that they remain contained to function within a lymph node. In the course of the lymph, lymphocytes may be activated as part of the adaptive immune response. There is usually only one efferent vessel though sometimes there may be two, in contrast to the multiple afferent channels that bring lymph into the node. Medullary sinuses contain histiocytes (immobile macrophages) and reticular cells, the former of which, along with T and B cells, become activated in the presence of antigens through lymphatic flow. The fewer efferent vessels allow this flow to be slowed, providing time to activate and distribute a larger number of immune cells in the event of an infection.
=== Modern electronic cigarette: 2000s === Despite these earlier efforts, Hon Lik, a Chinese pharmacist and inventor, who worked as a research pharmacist for a company producing ginseng products, is frequently credited with the invention of the modern e-cigarette. Hon quit smoking after his father, also a heavy smoker, died of lung cancer. In 2001, he thought of using a high frequency, piezoelectric ultrasound-emitting element to vaporize a pressurized jet of liquid containing nicotine. This design creates a smoke-like vapor. Hon said that using resistance heating obtained better results and the difficulty was to scale down the device to a small enough size. Hon's invention was intended to be an alternative to smoking. Hon Lik sees the e-cigarette as comparable to the "digital camera taking over from the analogue camera." Ultimately, Hon Lik did not quit smoking. He is now a dual user, both smoking and vaping.
Sources: en.wikipedia.org
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.
Frequently measured outcomes include wound healing, blood vessel growth, and tissue repair markers. Some work examines gastrointestinal protection. The choice of endpoint depends on the model used.
Different routes of administration and different animal models require different amounts. Studies also use varied timelines and measurement methods. This variation makes it difficult to combine results into a single standardized figure.
It is a synthetic peptide built from fifteen amino acids, with a mass of roughly 1419 daltons. The sequence is reported to match a fragment of a protein present in human gastric juice. It is not a naturally circulating hormone.